SELECTIS HEALTH Terminates Material Agreement

TL;DR

**SELECTIS HEALTH just terminated a key contract, signaling a potential shift in their business strategy or financial outlook.**

AI Summary

SELECTIS HEALTH, INC. filed an 8-K on February 22, 2024, reporting the termination of a material definitive agreement on February 20, 2024. The filing indicates the company's business address is 8480 E. Orchard Road, Suite 4900, Greenwood Village, CO 80111, and its IRS number is 87-0340206. This event signifies a change in the company's contractual obligations.

Why It Matters

The termination of a material definitive agreement can significantly alter a company's strategic direction, financial obligations, or operational plans, potentially impacting future revenue or expenses.

Risk Assessment

Risk Level: medium — The termination of a material agreement can introduce uncertainty regarding future business operations and financial performance.

Key Players & Entities

• SELECTIS HEALTH, INC. (company) — Registrant
• February 20, 2024 (date) — Date of earliest event reported
• February 22, 2024 (date) — Filing date
• 8480 E. Orchard Road, Suite 4900, Greenwood Village, CO 80111 (company) — Business address of SELECTIS HEALTH, INC.
• 87-0340206 (dollar_amount) — IRS Employer Identification number

FAQ

Filing Documents

• form8-k.htm (8-K) — 32KB
• 0001493152-24-007578.txt ( ) — 196KB
• gbcs-20240220.xsd (EX-101.SCH) — 3KB
• gbcs-20240220_lab.xml (EX-101.LAB) — 33KB
• gbcs-20240220_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 3KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number (I.R.S. Employer Identification number) 8480 E. Orchard Road , Ste. 4900 , Greenwood Village , CO 80111 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (720) 680-0808 (Former name or former address, if changed since last report) Written communications pursuant to Rule 425 under the Securities Act Soliciting material pursuant to Rule 14a-12 under the Exchange Act Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as dened in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised nancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT Effective February 20, 2024, Selectis Health, Inc., a Utah corporation (the " Company ") received written notice from the Purchaser (" Purchaser ") under the Purchase and Sale Agreement (" PSA ") and Operations Transfer Agreement (" OTA ") for the sale of certain of its Georgia subsidiaries, as previously reported on its Current Report on Form 8-K dated November 30, 2023 and filed with the Securities and Exchange Commission on December 5, 2023, that the Purchaser was terminating the PSA and OTA without consummation. In the notice the Purchaser claimed several Events of Default by the Company under the PSA and OTA. The Company categorically denies that those claimed Events of Default occurred. The Company intends to pursue any and all rights and remedies in the matter. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Selectis Health, Inc. (Registrant) Dated: February 22, 2024 /s/ Adam Desmond Adam Desmond, Interim CEO

View Full Filing

View this 8-K filing on SEC EDGAR